Public Employees Retirement Association of Colorado Cuts Stock Holdings in Kenvue Inc. (NYSE:KVUE)

Public Employees Retirement Association of Colorado reduced its stake in Kenvue Inc. (NYSE:KVUE) by 0.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 260,881 shares of the company’s stock after selling 2,045 shares during the quarter. Public Employees Retirement Association of Colorado’s holdings in Kenvue were worth $5,570,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also bought and sold shares of the stock. Handelsbanken Fonder AB increased its holdings in shares of Kenvue by 2.9% in the 4th quarter. Handelsbanken Fonder AB now owns 742,184 shares of the company’s stock worth $15,846,000 after buying an additional 21,222 shares during the last quarter. Alberta Investment Management Corp increased its holdings in shares of Kenvue by 23.2% in the 4th quarter. Alberta Investment Management Corp now owns 582,895 shares of the company’s stock worth $12,445,000 after buying an additional 109,700 shares during the last quarter. Longbow Finance SA increased its holdings in shares of Kenvue by 5.0% in the 4th quarter. Longbow Finance SA now owns 280,568 shares of the company’s stock worth $5,990,000 after buying an additional 13,287 shares during the last quarter. Steward Partners Investment Advisory LLC increased its holdings in shares of Kenvue by 143.1% in the 4th quarter. Steward Partners Investment Advisory LLC now owns 47,938 shares of the company’s stock worth $1,023,000 after buying an additional 28,216 shares during the last quarter. Finally, CORDA Investment Management LLC. increased its holdings in shares of Kenvue by 1.4% in the 4th quarter. CORDA Investment Management LLC. now owns 1,253,096 shares of the company’s stock worth $26,754,000 after buying an additional 17,466 shares during the last quarter. 97.64% of the stock is currently owned by institutional investors.

Kenvue Trading Up 0.5 %

Shares of KVUE opened at $23.12 on Tuesday. The firm has a fifty day simple moving average of $23.04 and a two-hundred day simple moving average of $22.46. Kenvue Inc. has a twelve month low of $17.67 and a twelve month high of $24.46. The company has a quick ratio of 0.69, a current ratio of 1.00 and a debt-to-equity ratio of 0.66. The stock has a market capitalization of $44.36 billion, a P/E ratio of 43.62, a PEG ratio of 2.62 and a beta of 1.02.

Kenvue (NYSE:KVUE) last posted its earnings results on Thursday, February 6th. The company reported $0.26 EPS for the quarter, hitting the consensus estimate of $0.26. Kenvue had a net margin of 6.66% and a return on equity of 20.97%. On average, research analysts anticipate that Kenvue Inc. will post 1.14 EPS for the current year.

Kenvue Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, May 28th. Stockholders of record on Wednesday, May 14th will be given a $0.205 dividend. The ex-dividend date of this dividend is Wednesday, May 14th. This represents a $0.82 annualized dividend and a dividend yield of 3.55%. Kenvue’s dividend payout ratio is 154.72%.

Analysts Set New Price Targets

A number of equities analysts have recently commented on the stock. UBS Group decreased their price target on shares of Kenvue from $23.00 to $21.00 and set a “neutral” rating on the stock in a report on Friday, February 7th. Redburn Atlantic initiated coverage on shares of Kenvue in a report on Thursday, April 10th. They set a “neutral” rating and a $23.50 target price on the stock. Citigroup increased their target price on shares of Kenvue from $21.00 to $22.00 and gave the company a “neutral” rating in a report on Monday, April 14th. Canaccord Genuity Group increased their target price on shares of Kenvue from $24.00 to $29.00 and gave the company a “buy” rating in a report on Wednesday, March 5th. Finally, Evercore ISI initiated coverage on shares of Kenvue in a report on Monday, March 24th. They set an “in-line” rating and a $25.00 target price on the stock. Eight equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat, Kenvue currently has a consensus rating of “Hold” and a consensus price target of $24.42.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.